Clinical Trial Update: SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA)

View source ↗

Summary

A recruiting clinical trial called SENECA is investigating biomarkers in cerebral amyloid angiopathy, sponsored by Fondazione I.R.C.C.S. Istituto Neurologico Ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Amyloid Angiopathy

Snippet

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Conditions: Cerebral Amyloid Angiopathy | Status: RECRUITING